Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Remyelination Therapy in Multiple Sclerosis.
Age-effects in white matter using associated diffusion tensor imaging and magnetization transfer ratio during late childhood and early adolescence.
Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
Type I interferon in human autoimmunity.
Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Evaluation of plaque detection and optimum time of enhancement in acute attack multiple sclerosis after contrast injection.
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.
The utility of multimodal evoked potentials in multiple sclerosis prognostication.
The Treatment of Tremor.
Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis.
Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis.
Working memory performance of early MS patients correlates inversely with modularity increases in resting state functional connectivity networks.
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience.
Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis.
Long-term epidemiology of multiple sclerosis in the Northern Seville District.
Transfer of Methylprednisolone into Breast Milk in a Mother with Multiple Sclerosis.
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.
Label-free imaging to study phenotypic behavioural traits of cells in complex co-cultures.
Cancer specific risk in multiple sclerosis patients.
Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Back and forth in time: Directing age in iPSC-derived lineages.
Characterization of Compensatory Stepping in People with Multiple Sclerosis.
Pages
« first
‹ previous
…
660
661
662
663
664
665
666
667
668
…
next ›
last »